Drug and dietary interactions of warfarin and novel oral anticoagulants: an update
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug and dietary interactions of warfarin and novel oral anticoagulants: an update
Authors
Keywords
-
Journal
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
Volume 31, Issue 3, Pages 326-343
Publisher
Springer Nature
Online
2011-02-26
DOI
10.1007/s11239-011-0561-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Coadministration of Dabigatran Etexilate and Atorvastatin
- (2013) Joachim Stangier et al. American Journal of Cardiovascular Drugs
- Further Evidence of a Clinically Significant Levofloxacin-Warfarin Interaction
- (2011) Jeffrey J. Glasheen et al. SOUTHERN MEDICAL JOURNAL
- Hyperprothrombinemia as a Result of a Possible Warfarin and Intravaginal Miconazole Interaction
- (2011) Jeremy L. Thomas et al. SOUTHERN MEDICAL JOURNAL
- Fibrate/Statin Initiation in Warfarin Users and Gastrointestinal Bleeding Risk
- (2010) Hedi Schelleman et al. AMERICAN JOURNAL OF MEDICINE
- Cranberry Juice and Warfarin: When Bad Publicity Trumps Science
- (2010) Jennifer Zikria et al. AMERICAN JOURNAL OF MEDICINE
- Hemorrhage During Warfarin Therapy Associated With Cotrimoxazole and Other Urinary Tract Anti-infective Agents
- (2010) Hadas D. Fischer et al. ARCHIVES OF INTERNAL MEDICINE
- Effect of high-dose cranberry juice on the pharmacodynamics of warfarin in patients
- (2010) Chadwick K. Mellen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor
- (2010) Dagmar Kubitza et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Increased anticoagulant activity of warfarin used in combination with doxifluridine
- (2010) Masaru Nakajima et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate
- (2010) Joachim Stangier et al. CLINICAL PHARMACOKINETICS
- Drug interactions with antiretrovirals and warfarin
- (2010) Michelle D Liedtke et al. Expert Opinion On Drug Safety
- Statin use and lipid levels in older adults: National Health and Nutrition Examination Survey, 2001 to 2006
- (2010) Jennifer G. Robinson et al. Journal of Clinical Lipidology
- Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers
- (2010) Koichiro Ogata et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial
- (2010) Michael Rud Lassen et al. LANCET
- The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor
- (2010) Elisabeth Perzborn et al. NATURE REVIEWS DRUG DISCOVERY
- Comparative efficacy and safety of the novel oral anticoagulants dabigatran, rivaroxaban and apixaban in preclinical and clinical development
- (2010) Mike Ufer THROMBOSIS AND HAEMOSTASIS
- Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: Comparison with direct inhibitors of factor VIIa, XIa and thrombin
- (2010) Xiaosui Jiang et al. THROMBOSIS AND HAEMOSTASIS
- Apixaban versus enoxaparin in patients with total knee arthroplasty
- (2010) Jiahao Huang et al. THROMBOSIS AND HAEMOSTASIS
- Warfarin–Antiretroviral Interactions
- (2009) Michelle D Liedtke et al. ANNALS OF PHARMACOTHERAPY
- Prevalence of Use and the Risk of Adverse Effects Associated with Complementary and Alternative Medicine in a Cohort of Patients Receiving Warfarin
- (2009) Vivian Wy Leung et al. ANNALS OF PHARMACOTHERAPY
- Probable Interaction Between Warfarin and Marijuana Smoking
- (2009) Weeranuj Yamreudeewong et al. ANNALS OF PHARMACOTHERAPY
- Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome
- (2009) CIRCULATION
- Pharmacokinetics and Pharmacodynamics of the Direct Oral Thrombin Inhibitor Dabigatran in Healthy Elderly Subjects
- (2009) Joachim Stangier et al. CLINICAL PHARMACOKINETICS
- Warfarin Interactions With Substances Listed in Drug Information Compendia and in the FDA-Approved Label for Warfarin Sodium
- (2009) M Anthony et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- In Vitro Assessment of Metabolic Drug-Drug Interaction Potential of Apixaban through Cytochrome P450 Phenotyping, Inhibition, and Induction Studies
- (2009) L. Wang et al. DRUG METABOLISM AND DISPOSITION
- The Absence of an Interaction Between Warfarin and Cranberry Juice: A Randomized, Double-Blind Trial
- (2009) Jack Ansell et al. JOURNAL OF CLINICAL PHARMACOLOGY
- New oral anticoagulants: a practical guide for clinicians
- (2009) Ann K. Wittkowsky JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interaction Between Gemfibrozil and Warfarin: Case Report and Review of the Literature
- (2009) Dave L Dixon et al. PHARMACOTHERAPY
- Probable Warfarin Interaction with Menthol Cough Drops
- (2009) Karen Coderre et al. PHARMACOTHERAPY
- Intracerebral hemorrhage secondary to a warfarin-metronidazole interaction
- (2008) Amanda Howard-Thompson et al. American Journal Geriatric Pharmacotherapy
- Elevated International Normalized Ratio after concurrent ingestion of cranberry sauce and warfarin
- (2008) K. A. Mergenhagen et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Interactions Between Warfarin and Three Commonly Prescribed Fluoroquinolones
- (2008) Douglas N Carroll et al. ANNALS OF PHARMACOTHERAPY
- Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects
- (2008) M I Mohammed Abdul et al. BRITISH JOURNAL OF PHARMACOLOGY
- Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin??Inhibitor Dabigatran Etexilate
- (2008) Joachim Stangier CLINICAL PHARMACOKINETICS
- Warfarin With Fluoroquinolones, Sulfonamides, or Azole Antifungals: Interactions and the Risk of Hospitalization for Gastrointestinal Bleeding
- (2008) H Schelleman et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans
- (2008) N. Raghavan et al. DRUG METABOLISM AND DISPOSITION
- Apixaban, an oral direct Factor Xa inhibitor: awaiting the verdict
- (2008) Jennifer Carreiro et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, Are Not Affected by Moderate Hepatic Impairment
- (2008) Joachim Stangier et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Possible Antiretroviral Therapy–Warfarin Drug Interaction
- (2008) Patricia Pecora Fulco et al. PHARMACOTHERAPY
- Retrospective assessment of potential interaction between levofloxacin and warfarin
- (2008) Gabriel Mercadal Orfila et al. PHARMACY WORLD & SCIENCE
- The Role of Cytochrome P2C19 in R-warfarin Pharmacokinetics and its Interaction With Omeprazole
- (2008) Tsukasa Uno et al. THERAPEUTIC DRUG MONITORING
- Drug Interactions between Warfarin and Efavirenz or Lopinavir-Ritonavir in Clinical Treatment
- (2007) S. Bonora et al. CLINICAL INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search